AMRUTANJAN.NSライブシグナル | Getagraph.comで利益を最大化

Live Chart Being Loaded With Signals

Commentary (8 5月 2024 @ 18:59):

Stats
本日の出来高	126 924
平均出来高	110 852
時価総額	22.63B
EPS	INR0 ( 2024-02-08 )
次の収益日	( INR0 ) 2024-05-28
Last Dividend	INR2.60 ( 2023-09-14 )
Next Dividend	INR0 ( N/A )
P/E	51.16
ATR14	INR1.556 (0.20%)

ボリューム相関

長: -0.16 (neutral)

短: -0.03 (neutral)

Signal:(36.231) Neutral

Amrutanjan Health Care 相関

10 最も正の相関
MAHLOG.NS	0.945
BAJAJHCARE.NS	0.925
RHIM.NS	0.923
GINNIFILA.NS	0.921
SELMC.NS	0.919
MCLEODRUSS.NS	0.919
ONMOBILE.NS	0.914
CONFIPET.NS	0.914
EXCELINDUS.NS	0.912
JETFREIGHT.NS	0.91

10 最も負の相関
CIGNITITEC.NS	-0.934
CERA.NS	-0.931
GEEKAYWIRE.NS	-0.929
MARSHALL.NS	-0.929
KPITTECH.NS	-0.922
CLSEL.NS	-0.922
KRITI.NS	-0.921
IONEXCHANG.NS	-0.92
BLUESTARCO.NS	-0.919
NUCLEUS.NS	-0.912

知っていましたか？

相関は、2つの変数間の関係を説明する統計的指標です。相関係数は-1から1までの値を取り、-1は完全な負の相関（1つの変数が増加すると、もう一方は減少する）、1は完全な正の相関（1つの変数が増加すると、もう一方も増加する）、0は相関がないことを示します（変数間に関係がない）。

相関は、株式だけでなく、どの2つの変数間の関係にも適用できます。これは、金融、経済学、心理学などの分野で一般的に使用されています。

Amrutanjan Health Care 相関 - 通貨/商品

-0.25
( neutral )

-0.31
( neutral )

-0.41
( neutral )

-0.15
( neutral )

-0.83
( strong negative )

0.26
( neutral )

Amrutanjan Health Care 財務諸表

Annual	2022
収益:	INR3.80B
総利益:	INR1.98B (52.05 %)
EPS:	INR13.65

FY	2022
収益:	INR3.80B
総利益:	INR1.98B (52.05 %)
EPS:	INR13.65

FY	2022
収益:	INR4.05B
総利益:	INR2.25B (55.49 %)
EPS:	INR23.00

FY	2021
収益:	INR3.32B
総利益:	INR1.91B (57.72 %)
EPS:	INR20.94

Financial Reports:

No articles found.

Amrutanjan Health Care Dividends

(Q3/22)	(Q4/22)	(Q1/23)	(Q2/23)	(Q3/23)	(Q4/23)	(Q1/24)	(Q2/24)	(Q3/24)	(Q4/24)
INR2.60 (N/A)	INR1.000 (N/A)	INR1.000 (N/A)	INR0 (N/A)	INR2.60 (N/A)	INR0 (N/A)	INR0 (N/A)	INR0 (N/A)	INR0 (N/A)	INR0 (N/A)

Amrutanjan Health Care Dividend Information - Dividend Knight

Dividend Sustainability Score: 4.71 - low (56.34%) | Divividend Growth Potential Score: 5.33 - Stable (6.54%)

Very Unsafe

High risk of being cut

Unsafe

Heightened risk of being cut

Borderline

Moderate risk of being cut

Safe

Unlikely to be cut

Very Safe

Very unlikely to be cut

Information

First Dividend	INR0.500	2010-02-09
Last Dividend	INR2.60	2023-09-14
Next Dividend	INR0	N/A
Payout Date	0000-00-00
Next Payout Date	N/A
# dividends	34	--
Total Paid Out	INR32.80	--
Avg. Dividend % Per Year	0.38%	--
Score	3	--
Div. Sustainability Score	4.71
Div.Growth Potential Score	5.33
Div. Directional Score	5.02	--

Next Divdend (Est)
(2024-05-22)

INR2.78 Estimate 8.02 %

Dividend Stability

0.32 Poor

Dividend Score

3.00

Pay Frequency

Semi-Annually

Yearly Payout

Year	Amount	Yield
2010	INR0	0.00%
2011	INR0	0.00%
2012	INR0	0.00%
2013	INR0	0.00%
2014	INR0	0.00%
2015	INR0	0.00%
2016	INR0	0.00%
2017	INR0	0.00%
2018	INR1.950	0.71%
2019	INR2.15	0.75%
2020	INR2.35	0.54%
2021	INR4.40	0.88%
2022	INR4.60	0.49%
2023	INR3.60	0.50%
2024	INR0	0.00%

Dividend Commentary

The company's low Dividend Sustainability Score (DSS) highlights potential challenges in upholding its current dividend levels. However, its Dividend Growth Potential Score (DGPS) is only moderate, indicating limited growth potential. On the whole, the dividend outlook remains neutral, meriting close observation of both the company's financial health and growth prospects.

Top 10 dividend Companies for NSE

Symbol	Title	Last dividend	Frequency	Years Dividend	Yearly Dividend
SUTLEJTEX.NS	Dividend Junior	2023-08-18	Annually	18	1.03%
NDRAUTO.NS	Dividend Junior	2023-07-12	Annually	4	0.59%
ICICIGI.NS	Dividend Junior	2023-06-12	Annually	8	0.36%
CENTENKA.NS	Dividend Junior	2023-08-11	Annually	22	1.85%
RUBYMILLS.NS	Dividend Junior	2023-09-20	Annually	23	0.96%
LINCOLN.NS	Dividend Junior	2023-09-15	Annually	9	0.32%
GEECEE.NS	Dividend Junior	2023-09-08	Sporadic	18	0.97%
ARIHANTCAP.NS	Dividend Junior	2023-07-28	Annually	4	0.39%
TEXINFRA.NS	Dividend Junior	2023-09-18	Annually	20	0.18%
OPTIEMUS.NS	Dividend Junior	2023-06-07	Insufficient data to determine frequency	2	0.16%

Dividend Sustainability Score (DSS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
netProfitMarginTTM	0.112	1.500	7.77	10.00	[0 - 0.5]
returnOnAssetsTTM	0	1.200	0	0	[0 - 0.3]
returnOnEquityTTM	0.159	1.500	9.34	10.00	[0.1 - 1]
payoutRatioTTM	0	-1.000	0	0	[0 - 1]
currentRatioTTM	0	0.800	-5.00	-4.00	[1 - 3]
quickRatioTTM	0	0.800	-4.71	-3.76	[0.8 - 2.5]
cashRatioTTM	0	1.500	-1.111	-1.667	[0.2 - 2]
debtRatioTTM	0	-1.500	0	0	[0 - 0.6]
interestCoverageTTM	442.01	1.000	10.00	10.00	[3 - 30]
operatingCashFlowPerShareTTM	3.28	2.00	8.91	10.00	[0 - 30]
freeCashFlowPerShareTTM	3.28	2.00	8.36	10.00	[0 - 20]
debtEquityRatioTTM	0	-1.500	0	0	[0 - 2.5]
grossProfitMarginTTM	0.495	1.000	5.08	5.08	[0.2 - 0.8]
operatingProfitMarginTTM	0.140	1.000	9.20	9.20	[0.1 - 0.6]
cashFlowToDebtRatioTTM	0	1.000	-1.111	-1.111	[0.2 - 2]
assetTurnoverTTM	0	0.800	-3.33	-2.67	[0.5 - 2]
Total Score				4.71

Dividend Growth Score (DGS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
peRatioTTM	48.83	1.000	5.17	0	[1 - 100]
returnOnEquityTTM	0.159	2.50	9.58	10.00	[0.1 - 1.5]
freeCashFlowPerShareTTM	3.28	2.00	8.91	10.00	[0 - 30]
dividendYielPercentageTTM	0.619	1.500	10.00	0	[0 - 0.4]
operatingCashFlowPerShareTTM	3.28	2.00	8.91	10.00	[0 - 30]
payoutRatioTTM	0	1.500	0	0	[0 - 1]
pegRatioTTM	2.14	1.500	10.00	0	[0.5 - 2]
operatingCashFlowSalesRatioTTM	0.0240	1.000	-1.899	0	[0.1 - 0.5]
Total Score				5.33

Amrutanjan Health Care

Amrutanjan Health Care Limited manufactures, supplies, and sells ayurvedic pain balms, non-alcoholic beverages, and sanitary napkins. The company operates through OTC Products, Beverages, and Others segments. It provides pain management products comprising pain balms and roll-ons; and back pain roll-ons and lotions, body pain gels, and joint muscle sprays, as well as diclofenac, a non-steroidal anti-inflammatory drug. The company offers congestion management products that consists of cold rubs, cough syrups, nasal inhalers, and swas mints. It also provides sanitary napkins for women. In addition, the company offers corn caps; hand sanitizers; and juice drinks under the Fruitnik and Fruitnik Electro+ brand names, as well as operates a pain management center. It exports its products to the Middle East, Africa, South East Asia, and internationally. The company was formerly known as Amrutanjan Limited and changed its name to Amrutanjan Health Care Limited in 2007. Amrutanjan Health Care Limited was founded in 1893 and is based in Chennai, India.